Drug intelligence / Profile preview

detetrahydroconidendrin

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Detetrahydroconidendrin, also known as VB-3, is a lignan analogue. It is found in the extract of fruits of *Vitex negundo var. cannabifolia*, which is classified as an herbal medicine. The compound has been studied for its quantitative determination in biological matrices such as rat plasma and tissues following oral administration of the herbal extract.

Beyond the preview

Go deeper on detetrahydroconidendrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on detetrahydroconidendrin.

Explore the full profile